Diagnostic evaluation of carbon tetrachloride-induced rat hepatic cirrhosis model

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 1029-1038

  Lee, Gi Ppeum ^a   Jeong, Won Il ^a   Jeong, Da Hee ^a   Do, Sun Hee ^a   Kim, Tae Hwan ^a   Jeong, Kyu Shik ^a  

^a Kyungpook National University   (South Korea)

Author keywords

CCl4; Diagnosis of cirrhosis; Hepatic cirrhosis

Indexed keywords

CARBON TETRACHLORIDE; OLIVE OIL; SILYMARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B SCAN; COLLAGEN METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MODEL; EVALUATION; FATTY LIVER; HISTOGRAM; HISTOPATHOLOGY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MEAN GREY LEVEL; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; RATS; RATS, WISTAR;

EID: 17444419035     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Luster MI, Simeonova PP, Gallucci RM, Bruccoleri A, Blazka ME and Yucesoy B: Role of inflammation in chemical-induced hepatotoxicity. Toxicol Lett 120: 317-25, 2001.
2. Victor M and Eric O: Liver. Pediatrics 113: 1097-1106, 2004.
3. Reinhard S, Remy M and Reto B: The use of silymarin in treatment of liver disease. Drugs 61: 2035-2063, 2001.
4. Maclachlan NJ and Cullen JM: Chapter 2. Liver, biliary system, and exocrine pancreas. In: Tomson's Special Veterinary Pathology (Carlton WW, Zachary JF and McGavin MD, 2nd eds). Missouri, Mosby, pp. 94-96, 1995.
5. Thomas CJ, Ronald DH and Norval WK: Digestive system. In: Veterinary Pathology (6th ed). Maeyland, Lippincott Williams & Willkins, pp. 1098-1099, 1997.
6. Galambos JT: Alcoholic cirrhosis (in relation with cirrhosis in general). In: Bockus Gastroenterology (Berk JE, 4th ed). Philadelphia, W. B. Saunder Co., pp. 3012-3049, 1985.
7. Nord JH: Biopsy diagnosis if cirrhosis: blind percutaneous versus guided direct vision techniques. A review. Gastrointest Endosc 28: 102-104, 1982.
8. Piccinino F, Sangnelli E, Pasquale G and Giusti G: Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsied. J Hepatol 2(2): 165-173, 1986.
9. Espinoza P, Ducot B, Pelletier G, Attali P, Buffet C and David D: Interobserver agreement in the physical diagnosis of alcoholic liver disease. Dig Dis Sci 32: 244-247, 1987.
10. Tine F, Caltagirone M, Camma C, Cottone M, Carxi A and Filippazzo MG: Clinical indicates of compensated cirrhosis: a prospective study. In: Chronic Liver Damage (Dianzani MU and Gentilini P, eds). Amsterdam, Elsevier, pp. 197-198, 1990.
11. Giorgio A, Amoroso P, Lettieri G, Fico P, De Stefano G and Finelli L: Cirrhosis: value of caudate to right lobe ratio in diagnosis with US. Radiology 161: 443-445, 1986.
12. Lu LG, Zeng MD, Li CZ, Mao YM and Wan MB: Grading and staging of hepatic fibrosis, and its relationship with non-invasive diagnostic parameters. World J Gastroenterol 9: 2574-2578, 2003.
13. Harsinghani MG and Hahn PF: Computed tomography and magnetic resonance imaging evaluation of liver cancer. Gastroenterol Clin North Am 31: 759-776, 2002.
14. Martin DR: Magnetic resonance imaging of diffuse liver diseases. Top Magn Reson Imaging 13: 151-163, 2002.
15. Hung CH, Lu SN, Wang JH, Lee CM, Chen TM, Tung HD, Chen CH, Huang WS and Changchien CS: Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis. World J Gastroenterol 38: 153-157, 2003.
16. Tchelepi H, Rails PW, Radin R and Grant E: Sonography of diffuse liver disease. J Ultrasound Med 21: 1023-1032, 2002.
17. Zheng RQ, Wang QH, Lu MD, Xie SB, Ren J, Su ZZ, Cai YK and Yao JL: Liver fibrosis in chronic viral hepatitis: an ultrasonographic study. World J Gastroenterol 9(11): 2484-2489, 2003.
18. 4 an adequate model of human cirrhosis? Hepatology 3: 112-120, 1983.
19. Paquet KJ and Kamphausen U: The carbon-tetrachloride hepatotoxicity as a model of liver damage. Acta Hepatogastroenterol 22: 84, 1975.
20. 4-induced liver damage. Effects of antifibrotic agent. J Hepatol 16: 282-289, 1992.
21. Magliulo E, Carosi PG, Minoli L and Gorini S: Studies on the regenerative capacity of the liver in rats subjected to partial hepatectomy and treated with silymarin. Arzneim-Forsch Drug Res 257: 161-167, 1973.
22. Down WH, Chasseaud LF and Grundy RK: Effect of silybin on the hepatic microsomal drug metabolizing enzyme system in the rat. Arzneim-Forsch Drug Res 24: 1986-1988, 1974.
23. 4-induced liver cirrhosis by silymarin. Fundam Clin Pharmacol 3: 183-191, 1989.
24. Muriel P, Garcia-pina T, Perez-Alvarez V and Mourelle M: Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J App Toxicol 12: 439-442, 1992.
25. Ramellini G and Meldolesi J: Stabilization of isolated rat liver plasma membranes by treatment in vitro with silymarin. Arzneim Forsch 24: 806-808, 1974.
26. Dehmlow C, Erhard J and de Groot H: Inhibition of Kupffer cell function as an explanation for the hepatoprotective properties of silibinin. Hepatology 23: 749-754, 1996.
27. Kobayashi N, Ito M, Nakamura J, Cai J, Gao C, Hammel JM and Fox IJ: Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 31: 851-857, 2000.
28. Gabrielli GB, Capra F, Casaril M, Squarzoni S, Tognella P, Dagradi R, De Maria E, Colombari R, Corrocher R and De Sandre G: Serum laminin and type 3 procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis. Clim Chim Acta 265: 21-31, 1997.
29. Castera L, Hartmann DJ, Chapel F, Guettier C, Mall F, Lons T, Richardet JP, Grimbert S, Morassi O, Beaugrand M and Trinchet JC: Serum laminin and type 4 collagen are accurate markers of histologically severe alcoholoc hepatitis in patients with cirrhosis. J Hepatol 32: 412-418, 2000.
30. Layer G, Zuna I, Lorenz A, Zerban H, Haberkorn U, Bannasch P, van Kaick G and Rath U: Computerized ultrasound B-scan texture analysis of experimental diffuse parenchymal liver disease: correlation with histopathology and tissue composition. J Clin Ultrasound 19: 193-201, 1991.
31. Bamber JC and Hill CR: Acoustic properties of normal and cancerous human liver-2 dependence on pathological condition. Ultrasound Med Biol 7: 121-133, 1981.
32. Lin T, Ophir J and Potter G: Correlation of ultrasonic attenuation with pathologic fat and fibrosis in liver disease. Ultrasound Med Biol 14: 729-734, 1988.
33. Parker KJ, Asztely MS, Lerner RM, Schenk EA and Waag RC: In vivo measurement of ultrasound attenuation in normal and diseased liver. Ultrasound Med Biol 14: 127-136, 1988.